Brief: Protagonist Therapeutics Inc Exposure To Any Liquidity Concern At SVB Is Limited
10/03/2023 23:30
March 10 (Reuters) - Protagonist Therapeutics Inc
PTGX.O :
* PROTAGONIST THERAPEUTICS INC - EXPOSURE TO ANY LIQUIDITY
CONCERN
AT SVB IS LIMITED, CASH HELD AT SVB IS ABOUT $13 MILLION AS OF
MARCH 9, 2023
Source: (shorturl.at/gwFG8)
Further company coverage: PTGX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Protagonist Therapeutics
See all newsU.S. RESEARCH ROUNDUP-Adobe, Braveheart Bio, CACI International
US FDA approves Takeda, Protagonist's drug for rare blood cancer (updated)
US FDA approves Takeda, Protagonist's drug for rare blood cancer
Silence Therapeutics jumps after mid-stage trial data for blood cancer drug
Protagonist Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary